NEURIA is operated and funded by Innoplexus AG. Innoplexus AG is currently funded by its own revenue streams as well as private investors. Of note, none of these investors have a professional connection to the pharmaceutical industry. Whilst Innoplexus AG is a service provider to the pharmaceutical and related industries, NEURIA is operated independently of those business streams. Financial independence from investors directly linked to pharmaceutical or related companies is important for Innoplexus AG to avoid any potential conflict of interest and maintain freedom from potential lobbying influences in order to serve the needs of patients and their loved ones as best we can.
Comments are closed.